Huita Wu

机构：Fujian Medical University, Anhui Medical University, Zhongshan Hospital of Xiamen University, Second Affiliated Hospital of Anhui Medical University

发表论文 21 篇 · 总被引 1254 次 · h-index 9

代表论文

• Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study (2019 · Annals of Oncology · 被引 853)
• Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2 (2019 · Cancer Letters · 被引 133)
• UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells (2019 · Bioscience Reports · 被引 73)
• The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma (2018 · Laboratory Investigation · 被引 43)
• VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer (2010 · Journal of Surgical Oncology · 被引 33)
• <p>LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma</p> (2019 · Cancer Management and Research · 被引 25)